Patents by Inventor Benjamin P. Lewis

Benjamin P. Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100029003
    Abstract: The present invention generally relates to microRNAs such as vertebrate microRNA (miRNA), for example, mammalian miRNA. Various aspects of the invention are directed to the detection, production, or expression of miRNA. In one aspect, the invention provides systems and methods for identifying targets of miRNA sequences. For instance, in one embodiment, gene sequences comprising UTRs are compared with miRNA sequences to determine the degree of interaction, for example, by determining a free energy measurement between the miRNA sequence and the UTR, and/or by determining complementarity between at least a portion of the miRNA sequence and the UTR. In another aspect, the invention is directed to the regulation of gene expression using miRNA. For example, gene expression within a cell may be altered by exposing the cell to an oligonucleotide comprising a sequence that is substantially antisense to at least a portion of an miRNA region of the gene, for example, antisense to a 6-mer or 7-mer portion of the miRNA.
    Type: Application
    Filed: January 21, 2009
    Publication date: February 4, 2010
    Applicants: Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology
    Inventors: David Bartel, Benjamin P. Lewis, Matthew W. Jones-Rhoades, Christopher B. Burge
  • Patent number: 7149631
    Abstract: Computational methods identify alternate splice forms of known gene transcripts and isoforms that are subject to NMD (nonsense-mediated decay). These methods were used to identify thousands of human genes that generate alternative splice forms, and to demonstrate that about a third of these are subject to NMD. This high prevalence of NMD-targeted transcripts indicates a systemic way of regulating gene expression—by shunting gene expression to nonproductive splice variants. This endemic regulation is exploited to engineer regulation of gene expression, to characterize splice pathway components and to assay splice environments, for example, using NMD-regulated reporter genes.
    Type: Grant
    Filed: May 31, 2002
    Date of Patent: December 12, 2006
    Assignee: Regents of the University of California
    Inventors: Steven E. Brenner, Richard E. Green, Benjamin P. Lewis
  • Publication number: 20030228578
    Abstract: Computational methods identify alternate splice forms of known gene transcripts and isoforms that are subject to NMD (nonsense-mediated decay). These methods were used to identify thousands of human genes that generate alternative splice forms, and to demonstrate that about a third of these are subject to NMD. This high prevalence of NMD-targeted transcripts indicates a systemic way of regulating gene expression—by shunting gene expression to nonproductive splice variants. This endemic regulation is exploited to engineer regulation of gene expression, to characterize splice pathway components and to assay splice environments, for example, using NMD-regulated reporter genes.
    Type: Application
    Filed: May 31, 2002
    Publication date: December 11, 2003
    Applicant: The Regents of the University of California
    Inventors: Steven E. Brenner, Richard E. Green, Benjamin P. Lewis